COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article Access statistics

Viewed: 513

Emailed: 0

PDF Downloaded: 169

Indian Journal of Pathology and Oncology

Clinical Significance of CD34 & CD10 Expression in Pediatric Acute Lymphoblastic Leukemia

Full Text PDF Share on Facebook Share on Twitter

Author Details : Amritha Malini G, Rajeevan K, Ajith Kumar VT, Sathi PP, Aravindan KP

Volume : 4, Issue : 4, Year : 2017

Article Page : 564-569

Suggest article by email


Introduction: Prognostication of acute leukemia by detecting immunophenotypic marker expression on leukemic cells by flow cytometry is crucial in providing individualized treatment and improving outcome in Pediatric ALL (Acute lymphoblastic leukemia). The Aim of the study was to determine whether expression of CD34 and CD10 could be used as additional prognostic markers in predicting treatment response in Pediatric ALL cases.
Materials and Method: This study was conducted among 44 pediatric ALL cases diagnosed in 2 year period in a tertiary care centre in North Kerala. Peripheral smear (PS), & bone marrow (BM) were examined, clinical and laboratory parameters were studied and flow cytometry was done in all cases and expression of CD10 & CD34 were noted. Treatment response was assessed by examining peripheral smear on day 7 after treatment, BM after induction, Cerebrospinal fluid (CSF) examination during induction phase .All the cases were followed up.
Result: In our study it was observed that presence of blasts on day 7 peripheral smear and CSF were more in CD34 negative cases compared to CD34 positive cases. BM remission after induction, treatment response and good outcome on follow up were more among CD34 positive cases. The results were statistically significant for CD34 expression. CD10 expression alone was not found to be statistically associated with treatment response.
Conclusion: CD34 expression predicts treatment response and is a significant favourable prognostic factor in pediatric ALL cases. It can be included in risk stratification for planning treatment along with established parameters.

Pediatric ALL, CD34, CD10 flow cytometry, Treatment response

How to cite : Amritha Malini G, Rajeevan K, Ajith Kumar Vt, Sathi Pp, Aravindan Kp, Clinical Significance of CD34 & CD10 Expression in Pediatric Acute Lymphoblastic Leukemia. Indian J Pathol Oncol 2017;4(4):564-569

Copyright © 2017 by author(s) and Indian J Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (